
reported in
youarewithinthenorms.com
NORMAN J CLEMENT RPH., DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC., SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT BS., MS, MBA. HARVEY JENKINS, MD, PH.D., IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., M.B.A., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., EVELYN J. CLEMENT, IN THE SPIRIT OF WALTER F. WRENN III., MD., JULIE KILLINGSWORTH, IN THE SPIRIT OF FOREST TENNANT, MD., RENEE BLARE, RPH, DR. TERENCE SASAKI, MD LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, IN THE SPIRIT OF WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., IN THE SPIRIT OF RICHARD KAUL, MD., IN THE SPIRIT OF LEROY BAYLOR, JAY K. JOSHI MD., MBA, AISHA GARDNER, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
Empire of Shame: Exposing DEA Deception and Junk Science –

37th President of the United States: 1969 ‐ 1974
What is the Watergate parallel?
The Watergate parallel draws a direct comparison between federal agency overreach and the political deception of President Richard Nixon’s administration during the 1970s Watergate scandal:

- Machiavellian Secrecy and Power Abuse: Just as Nixon’s administration relied on political manipulation, unethical tactics, and administrative secrecy to maintain authority and shield illegal conduct, federal enforcement agencies use deceptive data analytics and secret algorithms to target physicians and cover up policy failures.
- The Power of a Free Press: The fall of Nixon demonstrated that deeply entrenched government secrecy and institutional corruption can be dismantled when investigative journalists expose data withholding and unlawful practices to the public.

- Judicial Integrity and Accountability: Nixon was ultimately forced to resign through a combination of robust investigative reporting and judicial accountability. The sources argue that current federal healthcare overreach can similarly be exposed and checked through strong courtroom defense strategies—such as the federal jury acquittal of Dr. Lesly Pompy—paired with FOIA transparency demands and media scrutiny.

BY
July 30, 2026

When the DEA became my patient’s doctor
I have practiced neurology for more than fifty years. I have treated patients with refractory neuropathic pain, central pain syndromes, spinal cord injuries, and the cruel mix of conditions that fall under no clean diagnostic label. I have watched patients who were finally stable, finally sleeping, finally functioning, lose their prescriptions not because their physicians did anything wrong, but because the government decided that looking different on paper is the same as dealing drugs.
That is not hyperbole. It is the logical endpoint of a policy drift that has quietly transformed federal drug enforcement into de facto medical regulation.

How we got here
The opioid crisis was real, and federal attention was warranted. But the response conflated two very different problems: the surge in overdose deaths, which by the early 2020s was overwhelmingly driven by illicit fentanyl, and the legitimate prescribing of opioids for chronic pain. When those problems were treated as one, the remedy- aggressive DEA and DOJ enforcement against prescribing physicians- fell on the wrong target.

The 2016 CDC opioid guideline was intended as flexible clinical guidance. It was rapidly converted into a rigid enforcement tool. Dosage thresholds designed to prompt clinical reflection became quasi-mandatory ceilings. Prescribing outlier status, being in the top percentile of a regional database, started functioning as evidence of criminal intent. Physicians who treated the hardest cases, the sickest patients, the ones nobody else would see, found themselves in the crosshairs.

What happens to patients
The harms are not abstract. When physicians fear prosecution for treating chronic pain, they stop treating chronic pain. Patients with years of documented stability are force-tapered or abandoned. The medical literature on involuntary opioid tapering is sobering: withdrawal, functional collapse, psychological crisis, emergency department visits, and in the worst cases, death by suicide or illicit drug substitution.

Patients with neurologic pain conditions are especially vulnerable. Neuropathic pain, central sensitization, and mixed pain syndromes do not respond to uniform protocols. These patients often need individualized, long-term management that will never fit a simple dosage algorithm. When enforcement policy treats unusual but legitimate treatment as presumptive evidence of crime, clinicians who care for these patients face a stark choice: accept the legal risk or abandon the patient. Most choose to protect themselves. The patients lose.

What the Supreme Court actually said
Two Supreme Court decisions deserve far wider attention among practicing physicians. In Gonzales v. Oregon (2006), the Court held that the Controlled Substances Act does not authorize the Attorney General to declare a state-authorized medical practice illegitimate through executive action. The CSA targets drug diversion. It is not a national medical-practice code, and the federal executive branch cannot use it to define the standards of clinical care.
In Ruan v. United States (2022), the Court held that to convict a registered physician under the CSA, the government must prove that the physician knowingly acted outside the bounds of legitimate prescribing. It is not enough to show that a hypothetical expert would have done things differently. Malpractice and criminal distribution are not the same thing, and the law must treat them differently.

Those holdings set real limits. The problem is that enforcement culture has not fully absorbed them. Prosecutors still use outlier algorithms and nonbinding guidance as proxies for criminal intent. The gap between what the Supreme Court permits and what actually happens in investigations and prosecutions remains wide.



What needs to change
The fix is not to stop pursuing genuine diversion. Pill mills and sham practices should be prosecuted. The fix is to restore the line between law enforcement and medicine. Congress should amend the CSA to prohibit DEA and DOJ from using dosage thresholds, prescribing outlier status, or nonbinding guidance as stand-alone definitions of unlawful prescribing. Criminal liability for registered physicians should require proof of subjective criminal intent, as Ruan already demands, and jury instructions should make that standard explicit.

Before major prosecutions of pain-treating physicians, the Department of Justice should be required to obtain independent clinical review from board-certified specialists in pain medicine, neurology, or palliative care. The reviewer’s task is simple: Does this look like diversion, or does it look like a physician treating difficult patients under difficult conditions? When enforcement actions disrupt active pain practices, there must be continuity-of-care protections. Stable patients must not be left without medication and without options.

A call to the profession
The policy failure described here does not persist because nobody noticed. It persists because the medical profession has not responded with sufficient force. National specialty organizations issue position statements and move on. The physicians who are prosecuted face the system largely alone.
That has to change. Medical societies should build model frameworks distinguishing complex pain care from diversion, file amicus briefs in pending cases, and educate the judicial and legislative audiences that continue to conflate prescribing volume with criminal intent.

Patients in pain cannot wait. Many of them have already lost their physicians. Some have lost their lives. The profession that trained to treat them owes them more than silence.
Bill Bauer is a neurologist.

Dr. Tennant’s life represents a tireless battle to give scientific visibility to invisible physical suffering, leaving behind a blueprint for compassionate, specialized neurological care.
“drug dealers in white coats” for what may actually be good-faith medical disagreements or errors..”
…from Ruan vs. United States Case 21-1014

🔓 🔓 🔓
ALL WATCHED OVER BY MACHINES OF LOVING GRACE


ALL WATCHED OVER BY MACHINES OF LOVING GRACE
BE SURE TO DONATE TO THE MARK IBSEN GOFUNDME DEFENSE FUND, WHERE THE SON ALWAYS RISES!!!


FOR NOW, YOU ARE WITHIN
THE NORMs
